SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sulkowski MS. Hepatitis C virus infection in HIV-infected patients. Curr HIV/AIDS Rep 2004; 1: 128135.
  • 2
    Maida I, Nunez M, Gonzalez-Lahoz J, Soriano V. Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation? AIDS Res Hum Retroviruses 2005; 21: 599601.
  • 3
    Roland ME, Stock PG. Liver transplantation in HIV-infected recipients. Semin Liver Dis 2006; 26: 273284.
  • 4
    Schvarcz R, Rudbeck G, Soderdahl G, Ståhle L. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation 2000; 69: 21942195.
  • 5
    Carosi G, Puoti M, Antonucci G, De Luca A, Maserati R, Torti C, et al. Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection—statements of the First Italian Consensus Workshop. AIDS Rev 2005; 7: 161167.
  • 6
    Fredrick RT, Hassanein TI. Role of growth factors in the treatment of patients with HIV/HCV coinfection and patients with recurrent hepatitis C following liver transplantation. J Clin Gastroenterol 2005; 39(suppl): S14S22.
  • 7
    Fix OK, Andersen J, Koziel MJ. The impact of polymorphisms in inflammation-related genes on the severity of liver disease and response to therapy in patients co-infected with HIV and hepatitis C. Hepatology 2006; 44: 675A.
  • 8
    Hong X, Yu RB, Sun NX, Wang B, Xu YC, Wu GL. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 2005; 11: 73027307.
  • 9
    Mangia A, Sontoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, et al. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 2004; 25: 103109.
  • 10
    Casanovas-Taltavull T, Ercilla MG, Gonzalez CP, Gil E, Viñas O, Cañas C, et al. Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance. Liver Transpl 2004; 10: 584594.
  • 11
    Doughty AL, Zekry A, Spencer JD, Turhan S, Painter D, McCaughan GW. Spontaneous clearance of hepatitis C virus infection post-liver transplantation is associated with rapidly changing quasispecies: a single case report. Liver Transpl 2000; 6: 648653.
  • 12
    Samonakis DN, Cholongitas E, Triantos CK, Griffiths P, Dhillon AP, Thalheimer U, et al. Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis. J Hepatol 2005; 43: 10911093.
  • 13
    Stock P. Don't judge a book by its cover: the unexpected solid organ transplantation in the HIV positive recipient [Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture]. Presented at: 57th Annual Meeting of the American Association for the Study of Liver Diseases; October 27-31, 2006; Boston, MA.
  • 14
    Sergi C, Arnold JC, Rau W. Single nucleotide insertion in the 5′-untranslated region of hepatitis C virus with clearance of the viral RNA in a liver transplant recipient during acute hepatitis B virus superinfection. Liver 2002; 22: 7982.
  • 15
    Sagnelli E, Coppola N, Messina V. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 2002; 36: 12851291.
  • 16
    Inoue K, Sekiyama K, Yamada M, Watanabe T, Yasuda H, Yoshiba M. Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol 2003; 38: 567572.
  • 17
    Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38: 12821288.
  • 18
    Ranieri R, Santambrogio C, Veronelli A, Pontiroli AE. Hepatitis C viremia persistently suppressed by HAART. Clin Infect Dis 2003; 36: 10861087.